drugset / Trial / NCT00520286

Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence

NCT00520286

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study will be to examine the safety and efficacy of modafinil in increasing number of methamphetamine non-use weeks in subjects with methamphetamine dependence.

Timeline

Start
2007-12
Primary completion
2009-12
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Modafinil Small molecule 200 mg
Comparator Modafinil Small molecule 400 mg